Caveolin-1 expression in thyroid neoplasia spectrum: Comparison of two commercial antibodies

Disease Markers

Volumn 33, Issue 6, 2012, Pages 321-331

  Janković, Jelena ^a   Paskaš, Svetlana ^a   Marečko, Ilona ^a   Božić, Vesna ^b   Cvejić, Dubravka ^a   Savin, Svetlana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

AV09019 (Sigma Aldrich) antibody; caveolin 1; immunohistochemistry; sc894 (Santa Cruz Biotechnology) antibody; Thyroid tumors

Indexed keywords

AV09019 ANTIBODY; CAVEOLIN 1; PROTEIN ANTIBODY; SC894 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 84872321028     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-00934     Document Type: Article

References (26)

1. A.Y. Chen, A. Jemal and E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005, Cancer 115 (2009), 3801-3807.
2. L. Davies and H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002, JAMA 295 (2006), 2164-2167.
3. O. Olaleye, U. Ekrikpo, R. Moorthy, O. Lyne, J.Wiseberg, M. Black and D. Mitchell, Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006, Eur Arch Otorhinolaryngol 268 (2011), 899-906.
4. S.J. Schonfeld, C. Lee and A. Berrington de Gonzalez, Medical exposure to radiation and thyroid cancer, Clin Oncol (R Coll Radiol) 23 (2011), 244-250.
5. M.A. Aldred, Y. Huang, S. Liyanarachchi, N.S. Pellegata, O. Gimm, S. Jhiang, R.V. Davuluri, A. de la Chapelle and C. Eng, Papillary and follicular thyroid carcinomas showdistinctly different microarray expression profiles and can be distinguished by a minimum of five genes, J Clin Oncol 22 (2004), 3531-3539.
6. Y. Ito, H. Yoshida, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, Y. Nakamura, K. Kakudo, K. Kuma and A. Miyauchi, Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma, Pathol Res Pract 201 (2005), 545-549.
7. R.G. Parton and K. Simons, The multiple faces of caveolae, Nat RevMol Cell Biol 8 (2007), 185-194.
8. T. Okamoto, A. Schlegel, P.E. Scherer and M.P. Lisanti, Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane, J Biol Chem 273 (1998), 5419-5422.
9. A.W. Cohen, R. Hnasko, W. Schubert and M.P. Lisanti, Role of caveolae and caveolins in health and disease, Physiol Rev 84 (2004), 1341-1379.
10. M. Bastiani and R.G. Parton, Caveolae at a glance, J Cell Sci 123 (2010), 3831-3836.
11. A.F. Quest, J.L. Gutierrez-Pajares and V.A. Torres, Caveolin-1: an ambiguous partner in cell signalling and cancer, J Cell Mol Med 12 (2008), 1130-1150.
12. C. Boscher and I.R. Nabi, Caveolin-1: role in cell signaling, Adv Exp Med Biol 729 (2012), 29-50.
13. T.M. Williams and M.P. Lisanti, Caveolin-1 in oncogenic transformation, cancer, and metastasis, Am J Physiol Cell Physiol 288 (2005), C494-506.
14. S. Murakami, M. Miyamoto, Y. Hida, Y. Cho, A. Fukunaga, T. Oshikiri, K. Kato, T. Kurokawa, M. Suzuoki, Y. Nakakubo, K. Hiraoka, T. Itoh, T. Shinohara, T. Morikawa, O. Okushiba, S. Kondo and H. Katoh, Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma, Br J Cancer 88 (2003), 1234-1238.
15. L. Shi, X.M. Chen, L. Wang, L. Zhang and Z. Chen, Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome, Cancer 109 (2007), 1523-1531.
16. J. Cui, L.R. Rohr, G. Swanson, V.O. Speights, T. Maxwell and A.R. Brothman, Hypermethylation of the caveolin-1 gene promoter in prostate cancer, Prostate 46 (2001), 249-256.
17. J.A. Engelman, X.L. Zhang and M.P. Lisanti, Sequence and detailed organization of the human caveolin?1 and ?2 genes located near the D7S522 locus (7q31.1).Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines, FEBS Lett 448 (1999), 221-230.
18. I. Tamaskar and M. Zhou, Clinical implications of caveolins in malignancy and their potential as therapeutic targets, Curr Oncol Rep 10 (2008), 101-106.
19. E. Burgermeister, M. Liscovitch, C. Rocken, R.M. Schmid and M.P. Ebert, Caveats of caveolin-1 in cancer progression, Cancer Lett 268 (2008), 187-201.
20. M.J. Costa, Y. Song, P. Macours, C. Massart, M.C. Many, S. Costagliola, J.E. Dumont, J. Van Sande and V. Vanvooren, Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling, Endocrinology 145 (2004), 1464-1472.
21. Y. Ito, H. Yoshida, K. Nakano, K. Kobayashi, T. Yokozawa, K. Hirai, F. Matsuzuka, N. Matsuura, K. Kakudo, K. Kuma and A. Miyauchi, Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid, Br J Cancer 86 (2002), 912-916.
22. S. Savin, D. Cvejic, T. Isic, I. Paunovic, S. Tatic andM. Havelka, Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation, Hum Pathol 39 (2008), 1656-1663.
23. D. Kim, H. Kim and J.S. Koo, Expression of caveolin-1, caveolin-2 and caveolin-3 in thyroid cancer and stroma, Pathobiology 79 (2012), 1-10.
24. T. Satoh, G. Yang, S. Egawa, J. Addai, A. Frolov, S. Kuwao, T.L. Timme, S. Baba and T.C. Thompson, Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients, Cancer 97 (2003), 1225-1233.
25. S. Garcia, J.P. Dales, E. Charafe-Jauffret, S. Carpentier-Meunier, L. Andrac-Meyer, J. Jacquemier, C. Andonian, M.N. Lavaut, C. Allasia, P. Bonnier and C. Charpin, Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype, Hum Pathol 38 (2007), 830-841.
26. H.J. Joo, D.K.Oh, Y.S.Kim, K.B. Lee and S.J.Kim, Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma, BJU Int 93 (2004), 291-296.